Nateglinide is an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used to treat type 2 diabetes mellitus. Among its listed roles, it functions as a EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor and a hypoglycemic agent. It is grouped under the following drug class(es): Hypoglycemics. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Starlix, Starsis and senaglinide. Its PubChem CID is 5311309.
Nateglinide
| CAS No | 105816-04-4 |
|---|---|
| Molecular Formula | C19H27NO3 |
| Molecular Weight | 317.4 g/mol |
| Synonyms | (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nateglinide is an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid.
The listed CAS number is 105816-04-4.
The listed molecular formula is C19H27NO3.
The listed molecular weight is 317.4 g/mol.
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid.
The source lists Starlix, Starsis and senaglinide.